
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6856709
[patent_doc_number] => 20030130210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic'
[patent_app_type] => new
[patent_app_number] => 10/274709
[patent_app_country] => US
[patent_app_date] => 2002-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9678
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10274709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/274709 | Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic | Oct 20, 2002 | Abandoned |
Array
(
[id] => 6797495
[patent_doc_number] => 20030176369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Stabilized azithromycin compositions'
[patent_app_type] => new
[patent_app_number] => 10/274097
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8584
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176369.pdf
[firstpage_image] =>[orig_patent_app_number] => 10274097
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/274097 | Stabilized azithromycin compositions | Oct 17, 2002 | Issued |
Array
(
[id] => 1141995
[patent_doc_number] => 06777393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-17
[patent_title] => '4-substituted-9-deoxo-9a-aza-9a homoerythromycin a derivative'
[patent_app_type] => B2
[patent_app_number] => 10/273879
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17467
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 828
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10273879
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/273879 | 4-substituted-9-deoxo-9a-aza-9a homoerythromycin a derivative | Oct 17, 2002 | Issued |
Array
(
[id] => 7143115
[patent_doc_number] => 20050118316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Maltitol crystals containing crystal of saccharide except maltitol and method for production thereof'
[patent_app_type] => utility
[patent_app_number] => 10/451778
[patent_app_country] => US
[patent_app_date] => 2002-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3096
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451778 | Maltitol crystals containing crystal of saccharide except maltitol and method for production thereof | Oct 16, 2002 | Abandoned |
Array
(
[id] => 7216824
[patent_doc_number] => 20040071740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases'
[patent_app_type] => new
[patent_app_number] => 10/267863
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3745
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20040071740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10267863
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/267863 | Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases | Oct 9, 2002 | Issued |
Array
(
[id] => 754563
[patent_doc_number] => 07018983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-28
[patent_title] => 'Treatment of migraine'
[patent_app_type] => utility
[patent_app_number] => 10/254454
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1938
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/018/07018983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10254454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/254454 | Treatment of migraine | Sep 24, 2002 | Issued |
Array
(
[id] => 6684184
[patent_doc_number] => 20030120048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Process for producing purified erythromycin'
[patent_app_type] => new
[patent_app_number] => 10/239523
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3590
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20030120048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239523
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239523 | Method for preparing purified erythromycin | Sep 22, 2002 | Issued |
Array
(
[id] => 1209670
[patent_doc_number] => 06713455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-30
[patent_title] => '6-O-carbamate-11,12-lacto-ketolide antimicrobials'
[patent_app_type] => B2
[patent_app_number] => 10/244184
[patent_app_country] => US
[patent_app_date] => 2002-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21073
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 293
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10244184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/244184 | 6-O-carbamate-11,12-lacto-ketolide antimicrobials | Sep 15, 2002 | Issued |
Array
(
[id] => 7349319
[patent_doc_number] => 20040047866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Immunomodulatory methods using carbohydrate antigens'
[patent_app_type] => new
[patent_app_number] => 10/238834
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 26910
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20040047866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10238834
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/238834 | Immunomodulatory methods using carbohydrate antigens | Sep 8, 2002 | Abandoned |
Array
(
[id] => 6788110
[patent_doc_number] => 20030139349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use'
[patent_app_type] => new
[patent_app_number] => 10/168210
[patent_app_country] => US
[patent_app_date] => 2002-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2972
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20030139349.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168210
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168210 | Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use | Sep 4, 2002 | Abandoned |
Array
(
[id] => 565537
[patent_doc_number] => 07462366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Drug delivery particle'
[patent_app_type] => utility
[patent_app_number] => 10/232265
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 8317
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10232265
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/232265 | Drug delivery particle | Aug 29, 2002 | Issued |
Array
(
[id] => 6761906
[patent_doc_number] => 20030125268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives'
[patent_app_type] => new
[patent_app_number] => 10/220222
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10170
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125268.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220222
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220222 | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives | Aug 27, 2002 | Abandoned |
Array
(
[id] => 6814276
[patent_doc_number] => 20030073826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Crystaline clindamycin free base'
[patent_app_type] => new
[patent_app_number] => 10/227902
[patent_app_country] => US
[patent_app_date] => 2002-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13587
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10227902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/227902 | Crystaline clindamycin free base | Aug 25, 2002 | Abandoned |
Array
(
[id] => 6814098
[patent_doc_number] => 20030073648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Crystaline clindamycin free base'
[patent_app_type] => new
[patent_app_number] => 10/228356
[patent_app_country] => US
[patent_app_date] => 2002-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13585
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073648.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228356
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228356 | Crystaline clindamycin free base | Aug 25, 2002 | Abandoned |
Array
(
[id] => 6814097
[patent_doc_number] => 20030073647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Crystaline clindamycin free base'
[patent_app_type] => new
[patent_app_number] => 10/227901
[patent_app_country] => US
[patent_app_date] => 2002-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13590
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073647.pdf
[firstpage_image] =>[orig_patent_app_number] => 10227901
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/227901 | Crystaline clindamycin free base | Aug 25, 2002 | Abandoned |
Array
(
[id] => 6697269
[patent_doc_number] => 20030109463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Novel macrolides'
[patent_app_type] => new
[patent_app_number] => 10/226760
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10972
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0109/20030109463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226760 | Methods of making macrolides | Aug 22, 2002 | Issued |
Array
(
[id] => 6774711
[patent_doc_number] => 20030018049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Azithromycin combination for emesis control in mammals'
[patent_app_type] => new
[patent_app_number] => 10/226994
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5497
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226994 | Azithromycin combination for emesis control in mammals | Aug 21, 2002 | Abandoned |
Array
(
[id] => 7964255
[patent_doc_number] => 06680300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-20
[patent_title] => 'Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents'
[patent_app_type] => B2
[patent_app_number] => 10/223183
[patent_app_country] => US
[patent_app_date] => 2002-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 28
[patent_no_of_words] => 11616
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223183 | Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents | Aug 18, 2002 | Issued |
Array
(
[id] => 892158
[patent_doc_number] => 07345023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Treatment of hyperproliferative conditions of body surfaces'
[patent_app_type] => utility
[patent_app_number] => 10/486648
[patent_app_country] => US
[patent_app_date] => 2002-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 7002
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486648 | Treatment of hyperproliferative conditions of body surfaces | Aug 11, 2002 | Issued |
Array
(
[id] => 6818256
[patent_doc_number] => 20030069214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Process for preparing saponin compounds'
[patent_app_type] => new
[patent_app_number] => 10/213363
[patent_app_country] => US
[patent_app_date] => 2002-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8770
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069214.pdf
[firstpage_image] =>[orig_patent_app_number] => 10213363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/213363 | Process for preparing saponin compounds | Aug 5, 2002 | Issued |